Impact of flavonols on cardiometabolic biomarkers: A meta-analysis of randomized controlled human trials to explore the role of inter-individual variability

Nutrients

Volumn 9, Issue 2, 2017, Pages

  Menezes, Regina ^a   Rodriguez Mateos, Ana ^b   Kaltsatou, Antonia ^c   González Sarrías, Antonio ^d   Greyling, Arno ^e   Giannaki, Christoforos ^f   Andres Lacueva, Cristina ^g   Milenkovic, Dragan ^h,i   Gibney, Eileen R ^j   Dumont, Julie ^k   Schär, Manuel ^l   Garcia Aloy, Mar ^g   Palma Duran, Susana Alejandra ^m   Ruskovska, Tatjana ⁿ   Maksimova, Viktorija ⁿ   Combet, Emilie ^m   Pinto, Paula ^a,o  

^a INSTITUTO DE TECNOLOGIA QUÍMICA E BIOLÓGICA   (Portugal)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF THESSALY   (Greece)

^d RESEARCH GROUP ON QUALITY   (Spain)

^e UNILEVER RESEARCH VLAARDINGEN   (Netherlands)

^f UNIVERSITY OF NICOSIA   (Cyprus)

^g UNIVERSITY OF BARCELONA   (Spain)

^h CRNH AUVERGNE   (France)

ⁱ UNIVERSITÉ CLERMONT AUVERGNE   (France)

^j UNIVERSITY COLLEGE DUBLIN   (Ireland)

^k UNIV LILLE   (France)

^l UNIVERSITY OF READING   (United Kingdom)

^m UNIVERSITY OF GLASGOW   (United Kingdom)

ⁿ GOCE DELCEV UNIVERSITY   (Macedonia)

^o POLYTECHNIC INSTITUTE OF SANTARÉM   (Portugal)

more..

Author keywords

Blood lipids; Blood pressure; Cardiovascular disease; Flavonols; Glucose; Interindividual variability; Meta analysis; Quercetin; Systematic review

Indexed keywords

AGLYCONE; BIOLOGICAL MARKER; DIHYDROMYRICETIN; FLAVONOL; FLAVONOL DERIVATIVE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; ISOQUERCITRIN; ISORHAMNETIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MYRICETIN; PLACEBO; QUERCETIN; QUERCETIN AGLYCONE; QUERCETIN DEHYDRATE; RUTOSIDE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; CHOLESTEROL; LIPID;

AGE; BODY MASS; CARDIOMETABOLIC RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DIET SUPPLEMENTATION; DYSLIPIDEMIA; GENDER; HEALTH STATUS; HIGH RISK PATIENT; HUMAN; HYPERTENSION; LIPID BLOOD LEVEL; META ANALYSIS; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RHEUMATOID ARTHRITIS; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; ADULT; ASIA; BLOOD; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; DIETARY SUPPLEMENT; FEMALE; MALE; MIDDLE AGED; RISK FACTOR;

ADULT; ASIA; BIOMARKERS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIETARY SUPPLEMENTS; FEMALE; FLAVONOLS; HUMANS; LIPIDS; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS;

EID: 85012280092     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu9020117     Document Type: Review

References (63)

1. Go, A.S.; Mozaffarian, D.; Roger, V.L.; Benjamin, E.J.; Berry, J.D.; Borden, W.B.; Bravata, D.M.; Dai, S.; Ford, E.S.; Fox, C.S. et al. Heart disease and stroke statistics-2013 update: A report from the american heart association. Circulation 2013, 127, e6-e245.
2. Ford, E.S.; Roger, V.L.; Dunlay, S.M.; Go, A.S.; Rosamond, W.D. Challenges of ascertaining national trends in the incidence of coronary heart disease in the united states. J. Am. Heart Assoc. 2014, 3, e001097.
3. Perk, J.; De Backer, G.; Gohlke, H.; Graham, I.; Reiner, Ž.; Verschuren, M.; Albus, C.; Benlian, P.; Boysen, G.; Cifkova, R.; et al. European guidelines on cardiovascular disease prevention in clinical practice (version 2012). Eur. Heart J. 2012, 33, 1635-1701.
4. Stone, N.J.; Robinson, J.; Lichtenstein, A.H.; Merz, C.N.B.; Blum, C.B.; Eckel, R.H.; Goldberg, A.C.; Gordon, D.; Levy, D.; Lloyd-Jones, D. M.; et al. ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation 2013 doi:10.1161/ 01.cir.0000437738.63853.7a.
5. Woodside, J.V.; Young, I.S.; McKinley, M.C. Fruit and vegetable intake and risk of cardiovascular disease. Proc. Nutr. Soc. 2013, 72, 399-406.
6. Wang, X.; Ouyang, Y.; Liu, J.; Zhu, M.; Zhao, G.; Bao, W.; Hu, F.B. Fruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer: Systematic review and dose-response metaanalysis of prospective cohort studies. BMJ 2014, 349, g4490.
7. Chong, M.F.; Macdonald, R.; Lovegrove, J.A. Fruit polyphenols and CVD risk: A review of human intervention studies. Br. J. Nutr. 2010, 104 (Suppl. 3), S28-S39.
8. Lecour, S.; Lamont, K.T. Natural polyphenols and cardioprotection. Mini Rev. Med. Chem. 2011, 11, 1191-1199.
9. Rangel-Huerta, O.D.; Pastor-Villaescusa, B.; Aguilera, C.M.; Gil, A. A systematic review of the efficacy of bioactive compounds in cardiovascular disease: Phenolic compounds. Nutrients 2015, 7, 5177-5216.
10. Alissa, E.M.; Ferns, G.A. Dietary fruits and vegetables and cardiovascular diseases risk. Crit. Rev. Food Sci. Nutr. 2015 doi:10.1080/10408398.2015.1040487.
11. Guo, Y.; Bruno, R.S. Endogenous and exogenous mediators of quercetin bioavailability. J. Nutr. Biochem. 2015, 26, 201-210.
12. P, P.; CN, S. Worldwide (poly)phenol intake: Assessment methods and identified gaps. Eur. J. Nutr. 2017 doi:10.1007/s00394-016-1354-2.
13. Zamora-Ros, R.; Knaze, V.; Rothwell, J.A.; Hemon, B.; Moskal, A.; Overvad, K.; Tjonneland, A.; Kyro, C.; Fagherazzi, G.; Boutron-Ruault, M.C.et al. Dietary polyphenol intake in europe: The european prospective investigation into cancer and nutrition (EPIC) study. Eur. J. Nutr. 2016, 55, 1359-1375.
14. Ibarra, M.; Moreno, L.; Vera, R.; Cogolludo, A.; Duarte, J.; Tamargo, J.; Perez-Vizcaino, F. Effects of the flavonoid quercetin and its methylated metabolite isorhamnetin in isolated arteries from spontaneously hypertensive rats. Planta Medica 2003, 69, 995-1000.
15. Ajay, M.; Achike, F.I.; Mustafa, A.M.; Mustafa, M.R. Effect of quercetin on altered vascular reactivity in aortas isolated from streptozotocin-induced diabetic rats. Diabetes Res. Clin. Pract. 2006, 73, 1-7.
16. Hollman, P.C.H.; Geelen, A.; Kromhout, D. Dietary flavonol intake may lower stroke risk in men and women. J. Nutr. 2010, 140, 600-604.
17. Wang, Z.-M.; Zhao, D.; Nie, Z.-L.; Zhao, H.; Zhou, B.; Gao, W.; Wang, L.-S.; Yang, Z.-J. Flavonol intake and stroke risk: A meta-analysis of cohort studies. Nutrition 2014, 30, 518-523.
18. Wang, Z.M.; Nie, Z.L.; Zhou, B.; Lian, X.Q.; Zhao, H.; Gao, W.; Wang, Y.S.; Jia, E.Z.; Wang, L.S.; Yang, Z.J. Flavonols intake and the risk of coronary heart disease: A meta-analysis of cohort studies. Atherosclerosis 2012, 222, 270-273.
19. Serban, M.C.; Sahebkar, A.; Zanchetti, A.; Mikhailidis, D.P.; Howard, G.; Antal, D.; Andrica, F.; Ahmed, A.; Aronow, W.S.; Muntner, P.; et al. Effects of quercetin on blood pressure: A systematic review and metaanalysis of randomized controlled trials. J. Am. Heart Assoc. Cardiovasc. Cerebrovasc. Dis. 2016, 5, e002713.
20. Sahebkar, A. Effects of quercetin supplementation on lipid profile: A systematic review and meta-analysis of randomized controlled trials. Crit. Rev. Food Sci. Nutr. 2015 doi:10.1080/10408398.2014.948609.
21. MEDLINE. Available online: http://www.ncbi.nlm.nih.gov/pubmed (accessed on 21 December 2015).
22. COPUS. Available online: http://www.scopus.com (accessed on 4 February 2016).
23. Web of Knowledge. Available online: http://apps.webofknowledge.com (accessed on 18 December 2015).
24. Clinical Trials.gov. Available online: (https ://www.clinicaltrials.gov/) (accessed on 4 February 2016).
25. International Clinical Trials Registry Platform. Available online: www.who.int/trialsearch/ (accessed on 4 February 2016).
26. Higgins, J.P.T.; Altman, D.G.; Sterne, J.A.C. (Eds.) Assessing risk of bias in included studies. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (Updated March 2011). The Cochrane Collaboration. 2011. Available online: www.handbook.cochrane.org (accessed on 20 September 2016).
27. Haidich, A.B. Meta-analysis in medical research. Hippokratia 2010, 14, 29-37.
28. Higgins, J.; Green, S. (Eds.) Assessing the quality of a body of evidence. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0. The Cochrane Collaboration. 2011. Available online: www.handbook.cochrane.org (accessed on 20 September 2016).
29. Egert, S.; Bosy-Westphal, A.; Seiberl, J.; Kürbitz, C.; Settler, U.; Plachta-Danielzik, S.; Wagner, A.E.; Frank, J.; Schrezenmeir, J.; Rimbach, G.; et al. Quercetin reduces systolic blood pressure and plasma oxidised lowdensity lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: A double-blinded, placebo-controlled cross-over study. Br. J. Nutr. 2009, 102, 1065-1074.
30. Pfeuffer, M.; Auinger, A.; Bley, U.; Kraus-Stojanowic I.; Laue, C.; Winkler, P.; Rüfer, C.E.; Frank, J.; Bösch-saadatmandi, C.; Rimbach, G.; et al. Effect of quercetin on traits of the metabolic syndrome, endothelial function and inflammation in men with different apoe isoforms. Nutr. Metab. Cardiovasc. Dis. 2013, 23, 403-409.
31. Brüll, V.; Burak, C.; Stoffel-Wagner, B.; Wolffram, S.; Nickenig, G.; Müller, C.; Langguth, P.; Alteheld, B.; Fimmers, R.; Naaf, S.; et al. Effects of a quercetin-rich onion skin extract on 24 h ambulatory blood pressure and endothelial function in overweight-to-obese patients with (pre-)hypertension: A randomised doubleblinded placebo-controlled cross-over trial. Br. J. Nutr. 2015, 114, 1263-1277.
32. Chopra, M.; Fitzsimons, P.E.E.; Strain, J.J.; Thurnham, D.I.; Howard, A.N. Nonalcoholic red wine extract and quercetin inhibit ldl oxidation without affecting plasma antioxidant vitamin and carotenoid concentrations. Clin. Chem. 2000, 46, 1162-1170.
33. Dower, J.I.; Geleijnse, J.M.; Gijsbers, L.; Zock, P.L.; Kromhout, D.; Hollman, P.C.H. Effects of the pure flavonoids epicatechin and quercetin on vascular function and cardiometabolic health: A randomized, double-blind, placebo-controlled, crossover trial. Am. J. Clin. Nutr. 2015, 101, 914-921.
34. Suomela, J.-P.; Ahotupa, M.; Yang, B.; Vasankari, T.; Kallio, H. Absorption of flavonols derived from sea buckthorn (Hippophaë rhamnoides L.) and their effect on emerging risk factors for cardiovascular disease in humans. J. Agric. Food Chem. 2006, 54, 7364-7369.
35. Larmo, P.S.; Yang, B.; Hurme, S.A.M.; Alin, J.A.; Kallio, H.P.; Salminen, E.K.; Tahvonen, R.L. Effect of a low dose of sea buckthorn berries on circulating concentrations of cholesterol, triacylglycerols, and flavonols in healthy adults. Eur. J. Nutr. 2009, 48, 277-282.
36. Shi, Y.; Williamson, G. Quercetin lowers plasma uric acid in pre-hyperuricaemic males: A randomised, double-blinded, placebo-controlled, cross-over trial. Br. J. Nutr. 2016, 115, 800-806.
37. Edwards, R.L.; Lyon, T.; Litwin, S.E.; Rabovsky, A.; Symons, J.D.; Jalili, T. Quercetin reduces blood pressure in hypertensive subjects. J. Nutr. 2007, 137, 2405-2411.
38. Conquer, J.A.; Maiani, G.; Azzini, E.; Raguzzini, A.; Holub, B.J. Supplementation with quercetin markedly increases plasma quercetin concentration without effect on selected risk factors for heart disease in healthy subjects. J. Nutr. 1998, 128, 593-597.
39. Chen, S.; Zhao, X.; Wan, J.; Ran, L.; Qin, Y.; Wang, X.; Gao, Y.; Shu, F.; Zhang, Y.; Liu, P.; et al. Dihydromyricetin improves glucose and lipid metabolism and exerts anti-inflammatory effects in nonalcoholic fatty liver disease: A randomized controlled trial. Pharmacol. Res. 2015, 99, 74-81.
40. Lu, T.M.; Chiu, H.F.; Shen, Y.C.; Chung, C.C.; Venkatakrishnan, K.; Wang, C.K. Hypocholesterolemic efficacy of quercetin rich onion juice in healthy mild hypercholesterolemic adults: A pilot study. Plant Foods Hum. Nutr. 2015, 70, 395-400.
41. Lee, K.H.; Park, E.; Lee, H.J.; Kim, M.O.; Cha, Y.J.; Kim, J.M.; Lee, H.; Shin, M.J. Effects of daily quercetinrich supplementation on cardiometabolic risks in male smokers. Nutr. Res. Pract. 2011, 5, 28-33.
42. Kim, J.; Cha, Y.J.; Lee, K.H.; Park, E. Effect of onion peel extract supplementation on the lipid profile and antioxidative status of healthy young women: A randomized, placebo-controlled, double-blind, crossover trial. Nutr. Res. Pract. 2013, 7, 373-379.
43. Choi, E.Y.; Lee, H.; Woo, J.S.; Jang, H.H.; Hwang, S.J.; Kim, H.S.; Kim, W.S.; Kim, Y.S.; Choue, R.; Cha, Y.J.; et al. Effect of onion peel extract on endothelial function and endothelial progenitor cells in overweight and obese individuals. Nutrition 2015, 31, 1131-1135.
44. Kim, K.A.; Yim, J.E. Antioxidative activity of onion peel extract in obese women: A randomized, doubleblind, placebo controlled study. J. Cancer Prev. 2015, 20, 202-207.
45. Zahedi, M.; Ghiasvand, R.; Feizi, A.; Asgari, G.; Darvish, L. Does quercetin improve cardiovascular risk factors and inflammatory biomarkers in women with type 2 diabetes: A double-blind randomized controlled clinical trial. Int. J. Prev. Med. 2013, 4, 777-785.
46. Javadi, F.; Eghtesadi, S.; Ahmadzadeh, A.; Aryaeian, N.; Zabihiyeganeh, M.; Foroushani, A.R.; Jazayeri, S. The effect of quercetin on plasma oxidative status, C-reactive protein and blood pressure in women with rheumatoid arthritis. Int. J. Prev. Med. 2014, 5, 293-301.
47. Weber, M.A.; Schiffrin, E.L.; White, W.B.; Mann, S.; Lindholm, L.H.; Kenerson, J.G.; Flack, J.M.; Carter, B.L.; Materson, B.J.; Ram, C.V.; et al. Clinical practice guidelines for the management of hypertension in the community: A statement by the American society of hypertension and the international society of hypertension. J. Clin. Hypertens. 2014, 16, 14-26.
48. Jellinger, P.S.; Smith, D.A.; Mehta, A.E.; Ganda, O.; Handelsman, Y.; Rodbard, H.W.; Shepherd, M.D.; Seibel, J.A. American association of clinical endocrinologists’ guidelines for management of dyslipidemia and prevention of atherosclerosis. Endocr. Pract. 2012, 18 (Suppl. 1), 1-78.
49. American Diabetes Association (ADA). Standards of medical care in diabetes: Classification and diagnosis of diabetes. Diabetes Care 2015, 38, S8-S16.
50. Larson, A.J.; Symons, J.D.; Jalili, T. Therapeutic potential of quercetin to decrease blood pressure: Review of efficacy and mechanisms. Adv. Nutr. 2012, 3, 39-46.
51. Parichatikanond, W.; Pinthong, D.; Mangmool, S. Blockade of the renin-angiotensin system with delphinidin, cyanin, and quercetin. Planta Medica 2012, 78, 1626-1632.
52. Perez-Vizcaino, F.; Duarte, J.; Jimenez, R.; Santos-Buelga, C.; Osuna, A. Antihypertensive effects of the flavonoid quercetin. Pharmacol. Rep. 2009, 61, 67-75.
53. Sahebkar, A.; Ferri, C.; Giorgini, P.; Bo, S.; Nachtigal, P.; Grassi, D. Effects of pomegranate juice on blood pressure: A systematic review and meta-analysis of randomized controlled trials. Pharmacol. Res. 2016, 115, 149-161.
54. Feringa, H.H.; Laskey, D.A.; Dickson, J.E.; Coleman, C.I. The effect of grape seed extract on cardiovascular risk markers: A meta-analysis of randomized controlled trials. J. Am. Diet. Assoc. 2011, 111, 1173-1181.
55. Peng, X.; Zhou, R.; Wang, B.; Yu, X.; Yang, X.; Liu, K.; Mi, M. Effect of green tea consumption on blood pressure: A meta-analysis of 13 randomized controlled trials. Sci. Rep. 2014, 4, 6251.
56. Hooper, L.; Kay, C.; Abdelhamid, A.; Kroon, P.A.; Cohn, J.S.; Rimm, E.B.; Cassidy, A. Effects of chocolate, cocoa, and flavan-3-ols on cardiovascular health: A systematic review and meta-analysis of randomized trials. Am. J. Clin. Nutr. 2012, 95, 740-751.
57. Zhu, Y.; Bo, Y.; Wang, X.; Lu, W.; Wang, X.; Han, Z.; Qiu, C. The effect of anthocyanins on blood pressure: A prisma-compliant meta-analysis of randomized clinical trials. Medicine 2016, 95, e3380.
58. Sahebkar, A.; Simental-Mendia, L.E.; Giorgini, P.; Ferri, C.; Grassi, D. Lipid profile changes after pomegranate consumption: A systematic review and meta-analysis of randomized controlled trials. Phytomedicine 2016, 23, 1103-1112.
59. Tokede, O.A.; Onabanjo, T.A.; Yansane, A.; Gaziano, J.M.; Djousse, L. Soya products and serum lipids: A meta-analysis of randomised controlled trials. Br. J. Nutr. 2015, 114, 831-843.
60. Wang, D.; Chen, C.; Wang, Y.; Liu, J.; Lin, R. Effect of black tea consumption on blood cholesterol: A metaanalysis of 15 randomized controlled trials. PLoS ONE 2014, 9, e107711.
61. Whelton, P.K.; He, J.; Appel, L.J.; Cutler, J.A.; Havas, S.; Kotchen, T.A.; Roccella, E.J.; Stout, R.; Vallbona, C.; Winston, M.C.; et al. Primary prevention of hypertension: Clinical and public health advisory from the national high blood pressure education program. J. Am. Med. Assoc. 2002, 288, 1882-1888.
62. Lloyd-Jones, D.M.; Morris, P.B.; Ballantyne, C.M.; Birtcher, K.K.; Daly, D.D., Jr.; DePalma, S.M.; Minissian, M.B.; Orringer, C.E.; Smith, S.C., Jr. ACC expert consensus decision pathway on the role of non-statin therapies for LDL-cholesterol lowering in the management of atherosclerotic cardiovascular disease risk: A report of the American college of cardiology task force on clinical expert consensus documents. J. Am. Coll. Cardiol. 2016, 68, 92-125.
63. Jia, L.; Liu, X.; Bai, Y.Y.; Li, S.H.; Sun, K.; He, C.; Hui, R. Short-term effect of cocoa product consumption on lipid profile: A meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 2010, 92, 218-225.